Non-Helicobacter pylori, Non-NSAIDs 소화성궤양

키워드

참고문헌 (75)

1. Kuipers EJ, "The prevalence of Helicobacter pylori in peptic ulcer disease", Aliment Pharmacol Ther, 9(2), pp.59~69 (1995)
2. Malfertheiner P, "Peptic ulcer disease", Lancet, 374, pp.1449~1461 (2009)
3. Peterson WL, "Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating Helicobacter pylori and reducing ulcer recurrence: RBC Helicobacter pylori Study Group", Aliment Pharmacol Ther, 10, pp.251~261 (1996)
4. Jyotheeswaran S, "Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified", Am J Gastroenterol, 93, pp.574~578 (1998)
5. Ciociola AA, "Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated", Am J Gastroenterol, 94, pp.1834~1840 (1999)
6. Boulos PB, "Possible absence of Helicobacter pylori in the early stages of duodenal ulceration", QJM, 95, pp.749~752 (2002)
7. Jang HJ, "Has peptic ulcer disease changed during the past ten years in Korea? a prospective multi-center study", Dig Dis Sci, 53, pp.1527~1531 (2008)
8. Kang JM, "Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center", Scand J Gastroenterol, 47, pp.36~42 (2012)
9. 윤혁, "High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up", Gut and Liver, 7(2), pp.175~181 (2013), 거트앤리버 발행위원회
10. Bytzer P, "Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis: results from a randomized trial with 2-year follow-up", Am J Gastroenterol, 96, pp.1409~1416 (2001)
11. Xia HH, "Clinical and endoscopic characteristics of non-Helicobacter pylori, non- NSAID duodenal ulcers: a long-term prospective study", Aliment Pharmacol Ther, 15, pp.1875~1882 (2001)
12. Hung LC, "Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study", Gastroenterology, 128, pp.1845~1850 (2005)
13. Wong GL, "High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers", Gastroenterology, 137, pp.525~531 (2009)
14. Jang MK, "Prospective study for the prevalence of Helicobacter pylori infection in patients with gastric ulcer and duodenal ulcer among Korean population", Korean J Med, 52, pp.457~465 (1997)
15. Park DH, "Peptic ulcer diseases in Korea", Korean J Med, 55, pp.437~445 (1998)
16. 김진주, "2007년도 3차기관에서 진단된 소화성궤양 환자의 임상상", 대한소화기학회지, 59(5), pp.338~346 (2012), 대한소화기학회
17. Chung IS, "Peptic ulcer disease in Korea", Korean J Helicobacter Up Gastrointest Res, 12, pp.19~22 (2012)
18. 김준성, "소화성 궤양의 원인과 역학", Korean Journal of Helicobacter Upper Gastrointestinal Research, 14(1), pp.1~5 (2014), 대한상부위장관ㆍ헬리코박터학회[DOI]
19. Yim JY, "Seroprevalence of Helicobacter pylori in South Korea", Helicobacter, 12, pp.333~340 (2007)
20. Kim JI, "Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005", Eur J Gastroenterol Hepatol, 21, pp.787~793 (2009)
21. Arroyo MT, "The prevalence of peptic ulcer not related to Helicobacter pylori or nonsteroidal anti-inflammatory drug use is negligible in southern Europe", Helicobacter, 9, pp.249~254 (2004)
22. Nishikawa K, "Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population", Eur J Gastroenterol Hepatol, 12, pp.635~640 (2000)
23. Sugiyama T, "Attributable risk of Helicobacter pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-Helicobacter pylori ulcers", Dig Dis Sci, 46, pp.307~310 (2001)
24. Tan HJ, "Changing epidemiology of Helicobacter pylori in Asia", J Dig Dis, 9, pp.186~189 (2008)
25. Iijima K, "Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia", World J Gastroenterol, 20, pp.706~713 (2014)
26. Quan C, "Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs", Am J Gastroenterol, 97, pp.2950~2961 (2002)
27. Kurata JH, "Meta-analysis of risk factors for peptic ulcer: nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking", J Clin Gastroenterol, 24, pp.2~17 (1997)
28. Korman MG, "Influence of cigarette smoking on healing and relapse in duodenal ulcer disease", Gastroenterology, 85, pp.871~874 (1983)
29. Friedman GD, "Cigarettes, alcohol, coffee and peptic ulcer", N Engl J Med, 290, pp.469~473 (1974)
30. Cryer B, "Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans", Gastroenterology, 102(4 Pt 1), pp.1118~1123 (1992)
31. McColl KE, "A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration", Gut, 34, pp.762~768 (1993)
32. Clarke CA, "Secretion of blood group antigens and peptic ulcer", Br Med J, 1, pp.603~607 (1959)
33. Peters MN, "Stressful life events, acid hypersecretion, and ulcer disease", Gastroenterology, 84, pp.114~119 (1983)
34. Raiha I, "Lifestyle, stress, and genes in peptic ulcer disease: a nationwide twin cohort study", Arch Intern Med, 158, pp.698~704 (1998)
35. Sinar DR, "Effects of oral potassium supplements on upper gastrointestinal mucosa: multicenter clinical comparison of three formulations and placebo", Clin Ther, 8, pp.157~163 (1986)
36. Graham DY, "Alendronate gastric ulcers", Aliment Pharmacol Ther, 13, pp.515~519 (1999)
37. Sharma R, "Clinical observation of the temporal association between crack cocaine and duodenal ulcer perforation", Am J Surg, 174, pp.629~632 (1997)
38. Doria MI Jr, "Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine: a clinical and pathologic study", Cancer, 73, pp.2042~2047 (1994)
39. Goddard AF, "Healing of duodenal ulcer after eradication of Helicobacter heilmannii", Lancet, 349, pp.1815~1816 (1997)
40. Arnar DO, "Primary cytomegalovirus infection and gastric ulcers in normal host", Dig Dis Sci, 36, pp.108~111 (1991)
41. Lohr JM, "Is herpes simplex virus associated with peptic ulcer disease", J Virol, 64, pp.2168~2174 (1990)
42. Hawkey CJ, "Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group", N Engl J Med, 338, pp.727~734 (1998)
43. Borody TJ, "Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication", Am J Gastroenterol, 87, pp.1390~1393 (1992)
44. Endoh K, "Effects of smoking and nicotine on the gastric mucosa: a review of clinical and experimental evidence", Gastroenterology, 107, pp.864~878 (1994)
45. Eastwood GL, "Is smoking still important in the pathogenesis of peptic ulcer disease", J Clin Gastroenterol, 25(1), pp.S1~7 (1997)
46. Malaty HM, "Are genetic influences on peptic ulcer dependent or independent of genetic influences for Helicobacter pylori infection", Arch Intern Med, 160, pp.105~109 (2000)
47. Zheng PY, "Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population", Gut, 47, pp.18~22 (2000)
48. Feldman M, "Life events stress and psychosocial factors in men with peptic ulcer disease: a multidimensional case-controlled study", Gastroenterology, 91, pp.1370~1379 (1986)
49. Hui WM, "Life events and daily stress in duodenal ulcer disease: a prospective study of patients with active disease and in remission", Digestion, 52, pp.165~172 (1992)
50. Freston JW, "Helicobacter pylori-negative peptic ulcers: frequency and implications for management", J Gastroenterol, 35(12), pp.29~32 (2000)
51. Chan FK, "Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen", N Engl J Med, 344, pp.967~973 (2001)
52. Arora OP, "Study of gastroduodenal abnormalities in chronic bronchitis and emphysema", Am J Gastroenterol, 50, pp.289~296 (1968)
53. Liang CC, "Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications", PLos One, 9, pp.e87952~ (2014)
54. Andriulli A, "Prevalence of peptic ulcer in patients with various hepatopathies", Minerva Med, 77, pp.1801~1805 (1986)
55. Fraser AG, "Gastric secretion and peptic ulceration in cirrhosis", J Hepatol, 19, pp.171~182 (1993)
56. Loginov AS, "The characteristics of peptic ulcer in subjects with concomitant ischemic heart disease", Ter Arkh, 70, pp.9~13 (1998)
57. Gasparoni P, "Primary hyperparathyroidism and peptic ulcer", Minerva Med, 80, pp.1327~1330 (1989)
58. Fielding JF, "Peptic ulceration in Crohn's disease (reional enteritis)", Gut, 11, pp.998~1000 (1970)
59. Callaghan J, "Aggressive Helicobacter pylori-negative peptic ulceration as the initial manifestation of Crohn's disease", Frontline Gastroenterol, 3, pp.201~205 (2012)
60. Roy PK, "Zollinger- Ellison syndrome: clinical presentation in 261 patients", Medicine (Baltimore), 79, pp.379~411 (2000)
61. Cherner JA, "Gastrointestinal dysfunction in systemic mastocytosis: a prospective study", Gastroenterology, 95, pp.657~667 (1988)
62. Urayama S, "Presentation and treatment of annular pancreas in an adult population", Am J Gastroenterol, 90, pp.995~999 (1995)
63. Gisbert JP, "Review article: Helicobacter pylorinegative duodenal ulcer disease", Aliment Pharmacol Ther, 30, pp.791~815 (2009)
64. Chey WD, "Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism", Am J Gastroenterol, 92, pp.446~450 (1997)
65. Dickey W, "Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies", Aliment Pharmacol Ther, 10, pp.289~293 (1996)
66. Lanas A, "Evidence of aspirin use in both upper and lower gastrointestinal perforation", Gastroenterology, 112, pp.683~689 (1997)
67. Laine L, "Helicobacter pylori: drowning in a pool of blood", Gastrointest Endosc, 49(3 Pt 1), pp.398~402 (1999)
68. Farinati F, "Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer", Eur J Cancer Prev, 2, pp.321~326 (1993)
69. Bayerdorffer E, "Topographic association between active gastritis and Campylobacter pylori colonisation", J Clin Pathol, 42, pp.834~839 (1989)
70. Dixon MF, "Classification and grading of gastritis: the updated Sydney System: International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
71. Hirschowitz BI, "Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer", Gastroenterology, 114, pp.883~892 (1998)
72. Benya RV, "Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I", Am J Med, 97, pp.436~444 (1994)
73. Prinz RA, "Localization of gastrinomas", Int J Pancreatol, 19, pp.79~91 (1996)
74. Gillen D, "Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole", Gut, 44, pp.468~475 (1999)
75. Sonnenberg A, "Predictors of duodenal ulcer healing and relapse", Gastroenterology, 81, pp.1061~1067 (1981)

관련 논문AI추천